Worldwide there has been a significant increase in the incidence of oropharyngeal squamous cell carcinoma (OPSCC) etiologically attributed to oncogenic human papillomavirus (HPV). Reliable and accurate identification and detection tools are important as the incidence of HPV-related cancer is on the rise. Several HPV detection methods for OPSCC have been developed and each has its own advantages and disadvantages in regard to sensitivity, specificity, and technical difficulty. This review summarizes our current knowledge of molecular methods for detecting HPV in OPSCC, including HPV DNA/RNA polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), p16 immunohistochemistry (IHC), and DNA/RNA in situ hybridization (ISH) assays. This summary may facilitate the selection of a suitable method for detecting HPV infection, and therefore may help in the early diagnosis of HPV-related carcinoma to reduce its mortality, incidence, and morbidity.

Infection of the oral cavity with high-risk human papillomavirus (HPV) has been implicated as one of the risk factors for the development of oral squamous cell carcinoma (OSCC). Among the high-risk HPV types, HPV 16 and 18 are the most common infective agents in oral cancers. This study aimed to compare the presence of high-risk HPV in genetic materials obtained from saliva, blood and tissues of OSCC patients in Malaysia. The genomic DNA was extracted from saliva (n=13), blood (n=59) and tissue (n=63) and subjected to polymerase chain reaction (PCR) amplification of human beta globin gene to confirm the presence and integrity of DNA. Positive amplification was then screened for high-risk HPV by nested PCR using MY11/09 and GP5+/6+ consensus primers, followed by a further confirmation by DNA sequencing of the positive samples. As a result, two saliva samples (2/13; 15.4%) were found to harbour HPV 16 and one tissue sample (1/63; 1.6%) was shown to be positive for HPV 18. However, none of the blood samples were positive for high-risk HPV. Thus, HPV is more likely to be found in the saliva of OSCC patients as compared to blood and tissue samples. The detection of high-risk HPV in OSCC patients is useful in deciding how to manage the patient as HPV-associated OSCC has better prognosis.

Worldwide there has been a significant increase in the incidence of oropharyngeal squamous cell carcinoma (OPSCC) etiologically attributed to oncogenic human papillomavirus (HPV). Reliable and accurate identification and detection tools are important as the incidence of HPV-related cancer is on the rise. Several HPV detection methods for OPSCC have been developed and each has its own advantages and disadvantages in regard to sensitivity, specificity, and technical difficulty. This review summarizes our current knowledge of molecular methods for detecting HPV in OPSCC, including HPV DNA/RNA polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), p16 immunohistochemistry (IHC), and DNA/RNA in situ hybridization (ISH) assays. This summary may facilitate the selection of a suitable method for detecting HPV infection, and therefore may help in the early diagnosis of HPV-related carcinoma to reduce its mortality, incidence, and morbidity.